Measurement of an apoptotic product in the sera of breast cancer patients
- 1 April 2003
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 39 (6), 769-774
- https://doi.org/10.1016/s0959-8049(02)00865-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Novel High-Through-Put Assay for Screening of Pro-Apoptotic DrugsInvestigational New Drugs, 2002
- Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase‐related M30 CytoDeath antibodyHistopathology, 2001
- Nucleosomes in serum of patients with benign and malignant diseasesInternational Journal of Cancer, 2001
- Active Caspases and Cleaved Cytokeratins Are Sequestered into Cytoplasmic Inclusions in Trail-Induced ApoptosisThe Journal of cell biology, 2000
- Number of apoptotic cells as a prognostic marker in invasive breast cancerBritish Journal of Cancer, 2000
- Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosisThe Journal of Pathology, 1999
- Apoptosis Generates Stable Fragments of Human Type I KeratinsPublished by Elsevier BV ,1997
- Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell ApoptosisThe Journal of cell biology, 1997
- Apoptosis in breast cancer as related to histopathological characteristics and prognosisEuropean Journal of Cancer, 1994
- Isolation and characterization of DNA from the plasma of cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1987